Incyte Corporation (INCY)
Incyte Max Pain By Strike
INCY trades at $86.64, 23.8% above the near-term max pain of $70 expiring Sep 19, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($67.5-$85), indicating stable market expectations. High dispersion in max pain levels suggests competing forces and potential volatility.
Incyte Max Pain By Expiry
Max pain for INCY shows stable levels around 75.42, reflecting balanced market expectations. The 23% spread signals divergent expectations across timeframes. Most levels below 86.64 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 70 | -16.64 (-19.21%) |
| Oct 17, 2025 | 82.5 | -4.14 (-4.78%) |
| Dec 19, 2025 | 75 | -11.64 (-13.43%) |
| Jan 16, 2026 | 72.5 | -14.14 (-16.32%) |
| Mar 20, 2026 | 85 | -1.64 (-1.89%) |
| Jan 15, 2027 | 67.5 | -19.14 (-22.09%) |